Patients characteristics
A total of 255 consecutive patients with stage IB, II, or III GC or EGJC treated at the Medical Oncology Units of Fondazione Policlinico Universitario “A. Gemelli” IRCCS and University Hospital of Modena between…
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study)
